Urolithiasis Management Devices Market: Size, Share and Forecast for 2028

The TechSci Research report titled “Urolithiasis Management Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028” delineates the trajectory of the Global Urolithiasis Management Devices Market, indicating a value of USD 1.53 billion in 2022 and a projected Compound Annual Growth Rate (CAGR) of 4.77% from 2024 to 2028. This growth is notably attributed to the persistent rise in urolithiasis cases globally.

Kidney stones, although not a newfound health concern, have exhibited a consistent increase in prevalence since the early 20th century. This steady surge can be linked to various factors such as alterations in dietary patterns, sedentary lifestyles, and heightened consumption of specific foods, fostering a continual demand for advanced urolithiasis management devices.

Efforts aimed at broadening the accessibility of these devices are gaining traction, with initiatives focused on ensuring even underserved regions have access to cutting-edge technology and treatment options. Bridging this access gap holds paramount importance in addressing global disparities in urolithiasis care.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Global Urolithiasis Management Devices Market.” – https://www.techsciresearch.com/report/urolithiasis-management-devices-market/21201.html

According to NHS inform, the age group primarily affected by kidney stones falls between 30 and 60 years old, impacting about three out of 20 males and up to two out of 20 females during their lifetimes. Renal colic, characterized by excruciating pain caused by kidney stones, affects a substantial population, with approximately 500,000 individuals in the United States seeking emergency treatment for kidney stones each year, as reported by a May 2023 St. Pete Urology report.

Moreover, behaviors associated with sedentary lifestyles, including increased alcohol consumption and reduced water intake, contribute to kidney stone development. The escalating prevalence of obesity, identified as a high-risk factor for kidney stone formation, further propels the demand for urolithiasis management devices due to its association with sedentary living, poor dietary habits, and insufficient physical activity.

The European Association of Urology reports that kidney stones affect roughly 10% of the global population, with a recurrence rate of around 50% over a patient’s lifetime. This escalating incidence, coupled with the global inclination towards minimally invasive procedures, serves as a driving force behind the demand for urolithiasis management methods.

Treatment strategies for urinary stones are tailored to individual patient needs, considering factors such as stone size, categorized as up to 5 mm, 5-10 mm, 10-20 mm, and >20 mm or larger. The global market for urolithiasis management devices offers various treatment options, including Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, and other treatments.

Intracorporeal lithotripsy emerges as the dominant sector in treatment types, claiming the largest revenue share in 2022 and exhibiting a projected rapid CAGR throughout the forecasted period. This method involves the use of an endoscope and laser technology to visualize and disintegrate stones into manageable fragments, particularly suitable for patients with large stones. Despite its invasive nature, intracorporeal lithotripsy delivers a nearly 95% stone-free success rate, minimal implantation, and minimal to no apparent side effects, making it a preferred method for stone removal.

Conversely, ESWL remains a widely used, minimally invasive treatment, securing a significant share of revenue in 2022. This technique utilizes shock waves to break down stones, primarily effective for relatively smaller urinary stones, eliminating the need for hospital stays and appealing due to its accessibility and cost-effectiveness.

Hospitals & Clinics represent a substantial end-use sector in 2022, owing to increased investments in surgical infrastructure and favorable reimbursement policies. Conversely, Ambulatory Surgical Centers (ASCs) are anticipated to experience rapid growth due to their time-saving, cost-effective treatments, particularly for large obstructive urinary stones, along with technological advancements enabling painless stone removal procedures.

The continuous rise in urolithiasis cases necessitates ongoing innovations and advancements in treatment modalities, fostering a competitive landscape and opportunities for market expansion. This comprehensive analysis serves as a crucial guide for stakeholders in navigating and capitalizing on the evolving trends within the Global Urolithiasis Management Devices Market.

Major companies operating in Global Urolithiasis Management Devices Market are:

Allengers Medical Systems Ltd
Boston Scientific Corp
Cook Medical Inc
CONMED Corp
DiREX CORP
Dornier MedTech GmbH
HealthTronics Inc
Karl Storz SE & Co KG
Lumenis Inc
Siemens Healthcare Ltd

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global urolithiasis management devices market is poised for remarkable growth and innovation. Key trends include the shift towards minimally invasive procedures, personalized treatment plans, telemedicine adoption, innovative device development, data-driven care, and an emphasis on patient-centered care. The growing focus on preventive measures, improved global access, cross-disciplinary collaboration, and sustainability in healthcare further contribute to the changing landscape of urolithiasis management. As these trends continue to evolve, patients can expect a higher standard of care and more advanced treatment options for managing kidney stones. The future of urolithiasis management is characterized by a commitment to patient well-being, innovative technologies, and a global approach to care,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Urolithiasis Management Devices Market By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Urolithiasis Management Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Urolithiasis Management Devices Market.

Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=21201

LinkedIn – https://www.linkedin.com/pulse/urolithiasis-management-devices-market-dynamics-abipc/

Recently Published Report –

Urolithiasis Management Devices Market

Consumer Healthcare Market

United States Sex Reassignment Hormone Therapy Market

Medical Device Contract Manufacturing Market

Dental Impression Material Market

UAE Generic Drugs Market

Cognitive Assessment and Training In Healthcare Market

Contact Techsci Research–

US –